Traws Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Traws Pharma generated cash of -$17,932,000, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$17,936,000.
Cash Flow
| 2015 | -31.23M | 0 | 7.46M |
|---|---|---|---|
| 2017 | -23.82M | 0 | 6.36M |
| 2019 | -20.83M | -55K | 26.64M |
| 2020 | -23.07M | -15K | 19.35M |
| 2021 | -19.48M | 0 | 55.56M |
| 2022 | -16.29M | 0 | 0 |
| 2023 | -17.93M | -14K | 0 |
TRAW Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 38.75M | 55.07M | 19.02M | 22.72M | 16.97M | 21.45M | 43.58M |
Operating activities | |||||||
Net income | -18.94M | -18.96M | -16.16M | -25.15M | -21.50M | -24.09M | -24.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 16K | 14K | 14K | 13K | 14K | 88K | 150K |
Stock-based compensation expense | 1.30M | 1.17M | 576K | 369K | 0 | 0 | 3.78M |
| Deferred income tax benefit | 1.30M | 1.17M | 576K | 369K | 0 | 0 | 3.78M |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 11K | -1K | 9K | 61K | -63K | -28K | -1.37M |
Inventories | 0 | 1K | -9K | -61K | 0 | 0 | 0 |
Accounts payable | 1.75M | 1.10M | -2.07M | 562K | 232K | 863K | -606K |
Cash generated by operating activities | -17.93M | -16.29M | -19.48M | -23.07M | -20.83M | -23.82M | -31.23M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -14K | 0 | 0 | -15K | -55K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -14K | 0 | 0 | -15K | -55K | 0 | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 55.04M | 9.06M | 21.75M | 6.36M | 7.46M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 0 | 55.56M | 19.35M | 26.64M | 6.36M | 7.46M |
Net Change In Cash | -17.93M | -16.31M | 36.04M | -3.70M | 5.75M | -17.42M | -23.78M |
Cash at end of period | 20.82M | 38.75M | 55.07M | 19.02M | 22.72M | 4.02M | 19.79M |